Mental health issues often plague people with diabetes – regardless of the type they have or where they are on their diabetes journey. Although these issues are now recognised by the medical world as a secondary complication of #diabetes, the connection between mental health and diabetes is still rarely discussed openly. It’s time to talk and listen to #VoicesOfDiabetes. Find out in this candid interview with Santiago Paulos about his secret weapons for protecting his mental well-being against the daily grind of diabetes management: http://spkl.io/6049fpL5v #ConnectingWhatCounts #WorldDiabetesDay #MentalHealth #DiabetesLife #VoicesOfDiabetes
关于我们
罗氏是全球制药和诊断领域的领导者，致力于通过推动科学进步，改善人类生活。结合了制药和诊断两大业务的独特优势，使罗氏集团成为个体化医疗的领导者，通过个体化医疗为每一位患者提供最具针对性的治疗方案。 作为全球领先的生物技术公司之一，罗氏在抗肿瘤、免疫、抗感染、眼科和中枢神经系统领域拥有一流的差异化药物。罗氏在全球体外诊断和基于组织的肿瘤诊断领域享有领导地位，同时也是糖尿病管理领域的先驱者。 自1896年成立以来，罗氏始终致力于不断探索更好的疾病预防、诊断和治疗方案，持续为社会做出贡献。同时，公司不遗余力地与有关的利益相关方开展合作，提升患者对于创新药物的可及性。 在世界卫生组织基本药物目录中，有32个罗氏开发的药品，包括用以挽救生命的抗生素、抗疟药和抗肿瘤药物。罗氏连续11年位列道琼斯指数（DJSI）制药、生物技术和生命科学领域可持续发展的全球领导者。 罗氏总部位于瑞士巴塞尔，业务遍及全球150多个国家。2019年，罗氏全球拥有员工97,735名，研发投资120亿美元，总销售额达629亿美元。美国基因泰克公司（Genentech）是罗氏集团的全资子公司。此外，罗氏也是日本中外制药株式会社（Chugai）的控股方。 更多关于罗氏集团的信息，请登陆罗氏全球网站 www.roche.com。 #Roche #Biotechnology #Pharmaceuticals #Diagnostics #Healthcare #PersonalizedHealthcare #GreatPlaceToWork #Innovation
- 网站
-
http://www.roche.com/
罗氏公司的外部链接
- 所属行业
- 生物技术研究
- 规模
- 超过 10,001 人
- 总部
- Switzerland 🇨🇭
- 类型
- 上市公司
- 领域
- biotechnology、innovation、personalized healthcare、great place to work、diagnostics、pharmaceuticals、research、healthcare、personalised healthcare、diabetes care、genomics、healthcare technology、big data和Science
地点
罗氏公司员工
动态
-
Ever wonder what happens when brilliant young minds are put in a glass cube for five days and thrown in a real-world healthcare challenge? To find out, Roche in Basel hosted one of the teams of the InCube Challenge from October 14 to 18. This partnership with ETH Zürich connects our company with forward-thinkers worldwide who look at complex problems with fresh perspectives.
-
🌍At Roche, we believe a healthier planet means healthier lives. Our commitment to sustainability drives us to protect the environment, expand access to healthcare, and ensure ethical, transparent operations worldwide. Through innovations in healthcare, responsible resource management, and ethical business practices, we’re advancing sustainable, long-term value for patients, communities, and the planet.🌿💙 Learn more 👉 https://lnkd.in/djUJ5YRT Read more about sustainability at Roche here 👉 https://lnkd.in/dRsJvW23
-
-
Why is it important to advocate for people with diabetes? Shelley Rogers Landes' story is a powerful reminder of how pervasive diabetes stigma still is— especially for people living with type 2 diabetes. But Shelley hasn’t given up. There are a number of ways to tackle stigma and discrimination, and they all start with just a little kindness. Thank you, Shelley' for being so open as you share your story with the world. Learn more how to be a diabetes ally: http://spkl.io/6040fTmjs #ConnectingWhatCounts #WorldDiabetesDay #MentalHealth #DiabetesLife #VoicesOfDiabetes
-
Did you know that the global economy loses significant amounts every minute due to the gender health gap? It’s time to uncover the true cost of neglecting women’s health. Stay tuned for crucial insights! #TogetherForChange #XIndex #XProject Find out more at: http://spkl.io/6049fTOhF
-
The power of partnerships can transform healthcare and give us all more time with the people we love. Through collaboration with Algerian health authorities, we're paving the way for early detection and innovative treatment for breast cancer. As a mother diagnosed with breast cancer, Karima's story is a testament to the impact we can make when we work together. Join us in making a difference and creating a healthier future for women everywhere. Find out more at: http://spkl.io/6043frXoL
-
Thank you, Kyle Srinivasan, for sharing the great news that Roche has again been voted number one in the PatientView Corporate Reputation of Pharma breast cancer survey. Partnering with patient communities is so important to the work we do, and this recognition reflects that. Congratulations to the teams involved! #PatientCommunity #PatientEngagement #BreastCancer
Collaborating with the global breast cancer community to strategically advise on how to humanize healthcare in the interest of people living with breast cancer
I am proud to share that, for the second time in a row, the Roche group was voted number one in the PatientView Corporate Reputation of Pharma breast cancer survey, published earlier this year! Voted by patient groups, in areas of importance defined by them, this achievement reflects the value and impact of our work with the breast cancer patient community. Our commitment to working with patients is deeply rooted in our company philosophy of everything we do for patients, we do with patients, every step of the way. To have our efforts in breast cancer recognized by patient groups who know us or work with us, is incredibly uplifting. We have an ambitious vision for the future in breast cancer – that no one dies of this disease. Continuing to make progress towards this would not be possible without our partnerships with patient groups. The valuable insights they provide help guide our R&D and allow us to identify areas we can provide tailored support. I want to recognize the important contributions of the Roche breast cancer team, and, most of all, extend our thanks to all our patient and patient group partners for their continued collaboration. Annunziata Menna, Cammy Cheung Cláudia Echeverria Emilie Prazakova Esnath Muzenda Gaurav Jain Gunita Mitera Halima Okafor Jacqueline Wambua Lauren Davis Pariani Maria Julia Alves Batista Mona Van Steenberghe Naziah Lasi-Tejani Niki Ben Simon Noa Katz Sanjana Misra Poul Riese Eliyahu-Melamed Rachel Rebecca V. Spela (Mancek) Lalic Stefanie Klein
-
-
We are thrilled to announce that our pRED Innovation Center in Basel has been awarded by SEFA Labs the “SEFA Lab of the Year Award 2024”! 🏆 Presented annually by a jury of experts, the award recognizes the project team behind the most outstanding laboratory building. This is an incredible achievement for Roche and the project team, including the specialist planners and architects who brought this vision to life. Read more about it here: https://www.sefalabs.com/ A heartfelt thank you to everyone for making this happen! Geo Adam, Achim Grenz, Katrin Arnold, Werner Pietzonka, Marcus Hablützel, Ulrich Prutscher, Paul Kath, Markus von Grünigen, Dario Tonelli, Thore-Philipp Kuhn and Stefan Baumgartner #Winner #SEFA #Award #Lab #LaboftheYear
-
At Roche, our goal in breast cancer is to relentlessly pursue a cure. We’re focusing on three key areas of unmet needs – minimising the risk of the disease returning in early-stages, overcoming resistance to treatment, and reducing the risk of the cancer spreading to the brain. In our latest ‘Cancer Dialogue’ episode, Roche-Genentech’s Maura Dickler and expert Professor Peter Fasching met to talk about unmet needs, current and future focus areas. 👉 http://spkl.io/6049fON5x
-
👥 Where diversity thrives, people thrive. By embedding Diversity, Equity, and Inclusion into our daily practices, we empower everyone to bring their authentic selves to work. Through our Diversity Networks and inclusion initiatives, we foster a culture where collaboration, innovation, and wellbeing flourish. ✨ We believe that a workplace that embraces diversity leads to a healthier, more engaged team. 🤝 Want to learn more about our commitment to inclusion? Learn more ➡️ https://lnkd.in/dXk43hKC
-